93 related articles for article (PubMed ID: 28993636)
1. Involvement of PUF60 in Transcriptional and Post-transcriptional Regulation of Hepatitis B Virus Pregenomic RNA Expression.
Sun S; Nakashima K; Ito M; Li Y; Chida T; Takahashi H; Watashi K; Sawasaki T; Wakita T; Suzuki T
Sci Rep; 2017 Oct; 7(1):12874. PubMed ID: 28993636
[TBL] [Abstract][Full Text] [Related]
2. PUF60 promotes cell cycle and lung cancer progression by regulating alternative splicing of CDC25C.
Xu N; Ren Y; Bao Y; Shen X; Kang J; Wang N; Wang Z; Han X; Li Z; Zuo J; Wei GH; Wang Z; Zong WX; Liu W; Xie G; Wang Y
Cell Rep; 2023 Sep; 42(9):113041. PubMed ID: 37682709
[TBL] [Abstract][Full Text] [Related]
3. The Post-Transcriptional Regulatory Element of Hepatitis B Virus: From Discovery to Therapy.
Mouzannar K; Schauer A; Liang TJ
Viruses; 2024 Mar; 16(4):. PubMed ID: 38675871
[TBL] [Abstract][Full Text] [Related]
4. Cutting edges in the HBV genome: How RNA splicing is involved in modulating virus ultrastructure to promote infection.
Seitz S; Bartenschlager R
J Hepatol; 2024 Jun; 80(6):832-833. PubMed ID: 38460792
[No Abstract] [Full Text] [Related]
5. Efficacy of NVR 3-778, Alone and In Combination With Pegylated Interferon, vs Entecavir In uPA/SCID Mice With Humanized Livers and HBV Infection.
Klumpp K; Shimada T; Allweiss L; Volz T; Lütgehetmann M; Hartman G; Flores OA; Lam AM; Dandri M
Gastroenterology; 2018 Feb; 154(3):652-662.e8. PubMed ID: 29079518
[TBL] [Abstract][Full Text] [Related]
6. Host transcription factor Speckled 110 kDa (Sp110), a nuclear body protein, is hijacked by hepatitis B virus protein X for viral persistence.
Sengupta I; Das D; Singh SP; Chakravarty R; Das C
J Biol Chem; 2017 Dec; 292(50):20379-20393. PubMed ID: 29046350
[TBL] [Abstract][Full Text] [Related]
7. HBV RNA virion-like particles produced under nucleos(t)ide analogues treatment are mainly replication-deficient.
Wang J; Sheng Q; Ding Y; Chen R; Sun X; Chen X; Dou X; Lu F
J Hepatol; 2018 Apr; 68(4):847-849. PubMed ID: 29113914
[No Abstract] [Full Text] [Related]
8. Heparin at physiological concentration can enhance PEG-free in vitro infection with human hepatitis B virus.
Choijilsuren G; Jhou RS; Chou SF; Chang CJ; Yang HI; Chen YY; Chuang WL; Yu ML; Shih C
Sci Rep; 2017 Oct; 7(1):14461. PubMed ID: 29089529
[TBL] [Abstract][Full Text] [Related]
9. Interferon-stimulated gene 20 (ISG20) selectively degrades N6-methyladenosine modified Hepatitis B Virus transcripts.
Imam H; Kim GW; Mir SA; Khan M; Siddiqui A
PLoS Pathog; 2020 Feb; 16(2):e1008338. PubMed ID: 32059034
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the Hepatitis B virus replication and gene expression by the multi-functional protein TARDBP.
Makokha GN; Abe-Chayama H; Chowdhury S; Hayes CN; Tsuge M; Yoshima T; Ishida Y; Zhang Y; Uchida T; Tateno C; Akiyama R; Chayama K
Sci Rep; 2019 Jun; 9(1):8462. PubMed ID: 31186504
[TBL] [Abstract][Full Text] [Related]
11. Cell Type Diversity in Hepatitis B Virus RNA Splicing and Its Regulation.
Ito N; Nakashima K; Sun S; Ito M; Suzuki T
Front Microbiol; 2019; 10():207. PubMed ID: 30800119
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and genetic analysis of Verheij syndrome caused by PUF60 de novo mutation in a Chinese boy and literature review].
Liang Y; Ye J; Wei H; Ye F; Luo XP
Zhonghua Er Ke Za Zhi; 2018 Aug; 56(8):592-596. PubMed ID: 30078240
[No Abstract] [Full Text] [Related]
13. RBM24 stabilizes hepatitis B virus pregenomic RNA but inhibits core protein translation by targeting the terminal redundancy sequence.
Yao Y; Yang B; Cao H; Zhao K; Yuan Y; Chen Y; Zhang Z; Wang Y; Pei R; Chen J; Hu X; Zhou Y; Lu M; Wu C; Chen X
Emerg Microbes Infect; 2018 May; 7(1):86. PubMed ID: 29760415
[TBL] [Abstract][Full Text] [Related]
14. ENPP1 inhibits the transcription activity of the hepatitis B virus pregenomic promoter by upregulating the acetylation of LMNB1.
Ma X; Li Y; Zhu H; Lu K; Huang Y; Li X; Han S; Ding H; Sun S
Arch Virol; 2024 Jan; 169(2):36. PubMed ID: 38265511
[TBL] [Abstract][Full Text] [Related]
15. G-quadruplexes control hepatitis B virus replication by promoting cccDNA transcription and phase separation in hepatocytes.
Giraud G; Rodà M; Huchon P; Michelet M; Maadadi S; Jutzi D; Montserret R; Ruepp MD; Parent R; Combet C; Zoulim F; Testoni B
Nucleic Acids Res; 2024 Mar; 52(5):2290-2305. PubMed ID: 38113270
[TBL] [Abstract][Full Text] [Related]
16. Manipulation of metabolic responses enhances SHetA2 efficacy without toxicity in cervical cancer cell lines and xenografts.
Rai R; Lightfoot S; Benbrook DM
Gynecol Oncol; 2024 Jan; 180():44-54. PubMed ID: 38052108
[TBL] [Abstract][Full Text] [Related]
17. Identification of STAU1 as a regulator of HBV replication by TurboID-based proximity labeling.
Wei XF; Fan SY; Wang YW; Li S; Long SY; Gan CY; Li J; Sun YX; Guo L; Wang PY; Yang X; Wang JL; Cui J; Zhang WL; Huang AL; Hu JL
iScience; 2022 Jun; 25(6):104416. PubMed ID: 35663023
[TBL] [Abstract][Full Text] [Related]
18. Critical Updates on Chronic Hepatitis B Virus Infection in 2021.
Philips CA; Ahamed R; Abduljaleel JK; Rajesh S; Augustine P
Cureus; 2021 Oct; 13(10):e19152. PubMed ID: 34733599
[TBL] [Abstract][Full Text] [Related]
19. Identification of Therapeutic Targets for the Selective Killing of HBV-Positive Hepatocytes.
Huang CJ; Wang LH; Wang YC
J Pers Med; 2021 Jul; 11(7):. PubMed ID: 34357116
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus Core protein nuclear interactome identifies SRSF10 as a host RNA-binding protein restricting HBV RNA production.
Chabrolles H; Auclair H; Vegna S; Lahlali T; Pons C; Michelet M; Couté Y; Belmudes L; Chadeuf G; Kim Y; Di Bernardo A; Jalaguier P; Cosset FL; Fusil F; Rivoire M; Arnold LD; Lopatin U; Combet C; Zoulim F; Grierson D; Chabot B; Lucifora J; Durantel D; Salvetti A
PLoS Pathog; 2020 Nov; 16(11):e1008593. PubMed ID: 33180834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
